Oncology Institute Stock Market Value
| TOI Stock | USD 2.60 0.06 2.26% |
| Symbol | Oncology |
Is there potential for Health Care Equipment & Supplies market expansion? Will Oncology introduce new products? Factors like these will boost the valuation of Oncology Institute. If investors know Oncology will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Oncology Institute listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.67) | Revenue Per Share | Quarterly Revenue Growth 0.215 | Return On Assets | Return On Equity |
Investors evaluate Oncology Institute using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Oncology Institute's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Oncology Institute's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Oncology Institute's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncology Institute is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Oncology Institute's market price signifies the transaction level at which participants voluntarily complete trades.
Oncology Institute 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Oncology Institute's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Oncology Institute.
| 11/21/2025 |
| 02/19/2026 |
If you would invest 0.00 in Oncology Institute on November 21, 2025 and sell it all today you would earn a total of 0.00 from holding Oncology Institute or generate 0.0% return on investment in Oncology Institute over 90 days. Oncology Institute is related to or competes with Enhabit, Auna SA, Sonida Senior, Cross Country, Evolus, Treace Medical, and Orthopediatrics Corp. The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States More
Oncology Institute Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Oncology Institute's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Oncology Institute upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 42.16 | |||
| Value At Risk | (9.16) | |||
| Potential Upside | 6.53 |
Oncology Institute Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oncology Institute's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Oncology Institute's standard deviation. In reality, there are many statistical measures that can use Oncology Institute historical prices to predict the future Oncology Institute's volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (0.54) | |||
| Treynor Ratio | (0.12) |
Oncology Institute February 19, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.11) | |||
| Mean Deviation | 4.19 | |||
| Coefficient Of Variation | (2,391) | |||
| Standard Deviation | 5.98 | |||
| Variance | 35.79 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (0.54) | |||
| Treynor Ratio | (0.12) | |||
| Maximum Drawdown | 42.16 | |||
| Value At Risk | (9.16) | |||
| Potential Upside | 6.53 | |||
| Skewness | 1.52 | |||
| Kurtosis | 7.56 |
Oncology Institute Backtested Returns
Oncology Institute maintains Sharpe Ratio (i.e., Efficiency) of -0.0474, which implies the firm had a -0.0474 % return per unit of risk over the last 3 months. Oncology Institute exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Oncology Institute's Coefficient Of Variation of (2,391), variance of 35.79, and Risk Adjusted Performance of (0.02) to confirm the risk estimate we provide. The company holds a Beta of 2.09, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Oncology Institute will likely underperform. At this point, Oncology Institute has a negative expected return of -0.21%. Please make sure to check Oncology Institute's maximum drawdown, as well as the relationship between the accumulation distribution and price action indicator , to decide if Oncology Institute performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.7 |
Very good reverse predictability
Oncology Institute has very good reverse predictability. Overlapping area represents the amount of predictability between Oncology Institute time series from 21st of November 2025 to 5th of January 2026 and 5th of January 2026 to 19th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Oncology Institute price movement. The serial correlation of -0.7 indicates that around 70.0% of current Oncology Institute price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.7 | |
| Spearman Rank Test | -0.69 | |
| Residual Average | 0.0 | |
| Price Variance | 0.32 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Oncology Institute Correlation, Oncology Institute Volatility and Oncology Institute Performance module to complement your research on Oncology Institute. For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Oncology Institute technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.